Mass spectrometry-based analytical methods for quantification and identification of biological responses
The project seeks to identify and quantify drugs and biomarkers from biological samples by analysis with liquid chromatography-mass spectrometry (LC-MS) and other analytical methods. These analyses can either be performed to support other research projects or with a focus on developing of new analytical methods.
A primary goal of the project is to develop a robust method for quantification of dinucleotides that are excreted in urine following DNA damage. Other focus areas include analysis of vitamin D and vismodegib from different biological matrices.
Researcher
MSc. pharm. and PhD Jonatan Riber Granborg
Project supervisor
Associate Professor, PhD, MSc. Pharm. Catharina Margrethe Lerche
Project period
2022 -
Project collaborators
MSc. pharm. Anne Schmedes, Lillebælt Hospital, Vejle
Sigurd Hermansson, Waters Corporation, Solna, Sverige
Financing
The Lundbeck Foundation
Selected publications
Lerche CM, Philipsen PA, Hermansson S, Heydenreich J, Wulf HC. Quantification of Urinary Thymidine Dimers in Volunteers After Ultraviolet Radiation Using a New UPLC-MS/MS-based Method. Anitcancer Research. 2022 Oct;42(10):5069-5076.